Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

Phase: PHASE2 | Sponsor: Unity Health Toronto | Compound: Psilocybin

Status

recruiting

Institution

Unity Health Toronto

Start date

2025-03-05

End date

2026-12-01

Registry ID

NCT06731335

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.